VANDERLOCHT, Joris

Email Alert RSS Feed

Profile

Full Name
VANDERLOCHT, Joris
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 21 (Search time: 0.007 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12024Chronic disease patients have fewer social contacts: A pilot survey with implications for transmission dynamicsVANDERLOCHT, Joris; MOGELMOSE, Signe; VAN KERCKHOVE, Kim; Beutels, P.; HENS, NielJournal ContributionA1
22021Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemicsLIBIN, Pieter; WILLEM, Lander; Verstraeten, Timothy; TORNERI, Andrea; VANDERLOCHT, Joris; HENS, Niel; Perkins, AlexJournal ContributionA1
32020A prospect on the use of antiviral drugs to control local outbreaks of COVID-19TORNERI, Andrea; LIBIN, Pieter; VANDERLOCHT, Joris; Vandamme, Anne-Mieke; Neyts, Johan; HENS, NielJournal ContributionA1
42015Comment on "Dysregulated production of leukemia inhibitory factor in immune cells of relapsing remitting multiple sclerosis patients" by Levy et al. J. Neuroimmunol. 2015 Jan 15; 278C:85-89.VANDERLOCHT, Joris; HELLINGS, NielsJournal ContributionA1
52008Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imagingBAETEN, Kurt; HENDRIKS, Jerome; HELLINGS, Niels; THEUNISSEN, Evi; VANDERLOCHT, Joris; DE RYCK, Leen; GELAN, Jan; STINISSEN, Piet; ADRIAENSENS, PeterJournal ContributionA1
62008Leukaemia inhibitory factor induces an anti-apoptotic response in oligodendrocytes through Akt-phosphorylation and upregulation of 14-3-3SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; NOBEN, Jean-Paul; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
72008Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt-phosphorylation and up-regulation of 14-3-3SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; NOBEN, Jean-Paul; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
82007Leukemia inhibitory factor-mediated protection of oligodendrocytes: implications for multiple sclerosisSLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; Leprince, P.; ROBBEN, Johan; HENDRIKS, Jerome; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
92007Characterization of mature rat oligodendrocytes: a proteomic approachDUMONT, Debora; NOBEN, Jean-Paul; MOREELS, Marjan; VANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; LAMBRICHTS, Ivo; STINISSEN, Piet; ROBBEN, JohanJournal ContributionA1
102007The ambivalent nature of T-cell infiltration in the central nervous system of patients with multiple sclerosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
112007Immune mediated protection in multiple sclerosis: A role for neurokines in oligodendrocyte survival and macrophage modulationHELLINGS, Niels; HENDRIKS, Jerome; CARMANS, Sofie; SLAETS, Leen; DUMONT, Debora; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
122006Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-α-induced oligodendrocyte apoptosisVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; VANDENABEELE, Frank; MOREELS, Marjan; BUNTINX, Mieke; Hoekstra, D.; Antel, J.; STINISSEN, PietJournal ContributionA1
132006Current trends in multiple sclerosis research: an update on pathogenic conceptsVANDERLOCHT, Joris; HELLINGS, Niels; HENDRIKS, Jerome; STINISSEN, PietJournal ContributionA1
142006No association of leukemia inhibitory factor (LIF) DNA polymorphisms with multiple sclerosisVANDERLOCHT, Joris; BURZYKOWSKI, Tomasz; SOMERS, Veerle; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
152006Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionA1
162006Effects of IFN-beta, leptin and sinivastatin on LIF secretion by T lymphocytes of MS patients and healthy controlsVANDERLOCHT, Joris; HENDRIKS, Jerome; VENKEN, Koen; STINISSEN, Piet; HELLINGS, NielsJournal ContributionM
172006Influence of leukaemia inhibitory factor on macrophage function in vitro and during experimental autoimmune encephalomyelitisHENDRIKS, Jerome; HELLINGS, Niels; VANDERLOCHT, Joris; STINISSEN, PietJournal ContributionM
182006A Role for Leukemia Inhibitory Factor in Multiple Sclerosis: Implications for Immune-mediated Protection in the Central Nervous SystemVANDERLOCHT, JorisTheses and DissertationsT1
192004Leukemia inhibitory factor is produced by myelin reactive T-cells and protects against cytokine induced oligodendrocyte cell deathVANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; MOREELS, Marjan; Antel, J.; RAUS, Jef; STINISSEN, PietJournal ContributionM
202003Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: Morphology and oligodendrocyte-specific gene expressionBUNTINX, Mieke; VANDERLOCHT, Joris; HELLINGS, Niels; VANDENABEELE, Frank; LAMBRICHTS, Ivo; RAUS, Jef; AMELOOT, Marcel; STINISSEN, Piet; STEELS, PaulJournal ContributionA1
show all